Sodium aurothiomalate
CAS No. 12244-57-4
Sodium aurothiomalate( gold sodium thiomalate | Aurothiomalate sodium | Miochrysin | Myochrysine | Myocrisin | Myocrisine )
Catalog No. M23393 CAS No. 12244-57-4
Sodium aurothiomalate is a gold compound that is used for its immunosuppressive anti-rheumatic effects.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 42 | In Stock |
|
| 10MG | 65 | In Stock |
|
| 25MG | 132 | In Stock |
|
| 50MG | 205 | In Stock |
|
| 100MG | 335 | In Stock |
|
| 200MG | 494 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameSodium aurothiomalate
-
NoteResearch use only, not for human use.
-
Brief DescriptionSodium aurothiomalate is a gold compound that is used for its immunosuppressive anti-rheumatic effects.
-
DescriptionSodium aurothiomalate is a gold compound that is used for its immunosuppressive anti-rheumatic effects. Aurothiomalate sodium is a potent and selective inhibitor of oncogenic PKC-ι signaling. Aurothiomalate sodium is a potent thioredoxin reductase (TrxR) inhibitor. Aurothiomalate sodium exhibits potent anti-tumor activity.
-
In VitroWestern Blot Analysis Cell Line:Bovine arterial endothelial cells (BAEC)Concentration:25 uM Incubation Time:6 hours Result:Suppressed TNFa-induced NF-kB-dependent gene expression in a dose-dependent manner.
-
In VivoAnimal Model:4-6-week-old female nude mice with A427 or H460 cells Dosage:2, 6, 20 or 60 mg/kg Administration:Intramuscular injections; daily; 40 days Result:Exhibited statistically significant inhibition of tumor growth at all concentrations tested in A427 cell tumors because A427 cells are highly responsive.
-
Synonymsgold sodium thiomalate | Aurothiomalate sodium | Miochrysin | Myochrysine | Myocrisin | Myocrisine
-
PathwayAngiogenesis
-
TargetPKC
-
RecptorPKC-ι|TrxR
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number12244-57-4
-
Formula Weight390.07
-
Molecular FormulaC4H3AuNa2O4S
-
Purity>98% (HPLC)
-
SolubilityDMSO:Soluble
-
SMILESOC(CC(S)C(O)=O)=O.[x].[Na].[Au]
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Nummenmaa E, H?m?l?inen M, Moilanen LJ, Moilanen T, Vuolteenaho K, Moilanen E. TRPA1 expression is downregulated by dexamethasone and aurothiomalate in human chondrocytes: TRPA1 as a novel factor and drug target in arthritis. RMD Open. 2017 Sep 4;3(2):e000556.
molnova catalog
related products
-
[Ala113]-MBP (104-11...
Synthetic peptide analog of bovine myelin basic protein (MBP). Non-competitive inhibitor of PKC (IC50 = 28 - 62 mM).
-
Phorbol 12,13-dibuty...
Phorbol 12,13-dibutyrate (Phorbol dibutyrate) is a PKC activator that inhibits α1-adrenoceptor-mediated positive inotropic effects in a concentration-dependent manner, induced by contraction of isolated rabbit vascular smooth muscle.
-
Protein Kinase C 19-...
Protein Kinase C (19-36) is a pseudosubstrate peptide inhibitor of protein kinase C (PKC), with an IC50 of 0.18 μM.
Cart
sales@molnova.com